Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide Celgene Europe

lenalidomide · Celgene Europe Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lenalidomide Celgene Europe, covering 2008-06-04 to 2008-06-04. Get the full timeline:

Most recent: Celgene Europe Limited withdraws its marketing authorisation application for Lenalidomide Celgene Europe (lenalidomide)

See pricing